Tags Archive Navigation
icon
-
StoryNegative impact of the IRA on patient access to innovative treatments
-
StorySickle cell screening urged for newborns in Africa
-
StoryBoosting access to cancer care where it’s needed most
-
StoryPrioritizing the needs of patients
-
Media ReleaseNovartis and Hewlett Packard Enterprise join forces to advance Novartis global health efforts
-
Media ReleaseNovartis accelerates efforts toward ESG targets to increase access to medicines, improve health equity and achieve net-zero carbon emissions
-
Media ReleaseNovartis reinforces commitment to patient access, pricing a EUR 1.85 billion sustainability-linked bond
-
Media ReleaseSandoz announces agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics
-
Media ReleaseNovartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
-
StoryNovartis Access impact evaluation: progress update on our work with Boston University
-
StoryNovartis invites scrutiny of effort to improve access to medicine
-
StoryTeaching a daughter the power of purpose